Yunnan Baiyao Stock Hits Day Low of CNY 54.68 Amid Price Pressure

Yunnan Baiyao Group Co., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 3.17% on March 23, 2026. The stock reached an intraday low of CNY 54.68, reflecting broader market trends as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, Yunnan Baiyao's performance has also been under pressure, with a decrease of 3.26%, while the one-month performance shows a decline of 2.76%. In contrast, the stock has shown resilience over the past year, with a slight decrease of 0.25%, outperforming the Shanghai Composite, which gained 13.33% during the same period. The company's financial metrics indicate a solid foundation, with a return on equity (ROE) of 12.75% and a price-to-book ratio of 2.40. Additionally, Yunnan Baiyao has reported a high dividend yield of 2.26%, which may appeal to income-focused investors. Despite the recent downturn, the company has demonstrated a capacity for profit growth, with a net profit of CNY 4,709.49 million reported for the first nine months.